229 related articles for article (PubMed ID: 10984508)
1. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.
Tang XX; Zhao H; Robinson ME; Cohen B; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10936-41. PubMed ID: 10984508
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.
Tang XX; Zhao H; Robinson ME; Cnaan A; London W; Cohn SL; Cheung NK; Brodeur GM; Evans AE; Ikegaki N
Med Pediatr Oncol; 2000 Dec; 35(6):656-8. PubMed ID: 11107140
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
[TBL] [Abstract][Full Text] [Related]
4. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N
Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
[TBL] [Abstract][Full Text] [Related]
5. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
Ikegaki N; Gotoh T; Kung B; Riceberg JS; Kim DY; Zhao H; Rappaport EF; Hicks SL; Seeger RC; Tang XX
Clin Cancer Res; 2007 Oct; 13(20):6001-9. PubMed ID: 17947461
[TBL] [Abstract][Full Text] [Related]
6. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma.
Tang XX; Robinson ME; Riceberg JS; Kim DY; Kung B; Titus TB; Hayashi S; Flake AW; Carpentieri D; Ikegaki N
Clin Cancer Res; 2004 Sep; 10(17):5837-44. PubMed ID: 15355914
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
Tang XX; Brodeur GM; Campling BG; Ikegaki N
Clin Cancer Res; 1999 Feb; 5(2):455-60. PubMed ID: 10037197
[TBL] [Abstract][Full Text] [Related]
8. Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6.
Munthe E; Rian E; Holien T; Rasmussen A; Levy FO; Aasheim H
FEBS Lett; 2000 Jan; 466(1):169-74. PubMed ID: 10648835
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
[TBL] [Abstract][Full Text] [Related]
11. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Ren Y; Chan HM; Fan J; Xie Y; Chen YX; Li W; Jiang GP; Liu Q; Meinhardt A; Tam PK
Oncogene; 2006 Jun; 25(25):3501-8. PubMed ID: 16449971
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
15. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.
Takai N; Miyazaki T; Fujisawa K; Nasu K; Miyakawa I
Oncol Rep; 2001; 8(3):567-73. PubMed ID: 11295082
[TBL] [Abstract][Full Text] [Related]
16. Ephrins stimulate neurite outgrowth during early cortical neurogenesis.
Zhou X; Suh J; Cerretti DP; Zhou R; DiCicco-Bloom E
J Neurosci Res; 2001 Dec; 66(6):1054-63. PubMed ID: 11746437
[TBL] [Abstract][Full Text] [Related]
17. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
18. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
[TBL] [Abstract][Full Text] [Related]
19. Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.
Allonby O; El Zawily AM; Freywald T; Mousseau DD; Chlan J; Anderson D; Benmerah A; Sidhu V; Babu M; DeCoteau J; Freywald A
Cell Signal; 2014 Dec; 26(12):2645-57. PubMed ID: 25152371
[TBL] [Abstract][Full Text] [Related]
20. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
